Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
GRFS Grifols
- 7.080
- -0.070-0.98%
Close Apr 29 16:00 ET
- 7.190
- +0.110+1.55%
Pre 07:56 ET
4.82BMarket Cap27.02P/E (TTM)
7.219High7.060Low517.19KVolume7.180Open7.150Pre Close3.68MTurnover0.09%Turnover Ratio27.02P/E (Static)680.41MShares9.96052wk High0.83P/B3.97BFloat Cap5.79052wk Low--Dividend TTM560.96MShs Float24.966Historical High--Div YieldTTM2.23%Amplitude3.263Historical Low7.119Avg Price1Lot Size
About Grifols Company
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Company Profile
SymbolGRFS
Company NameGrifols
Listing DateJun 2, 2011
Founded1940
CEOMr. Jose Ignacio Abia Buenache
MarketNASDAQ
Employees23822
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressAvinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan,Sant Cugat del Vallès
CityBarcelona
ProvinceCatalonia
CountrySpain
Zip Code08174
Phone34-93-571-02-21
Websitehttp://www.grifols.com
Company Executives
- Name
- Position
- Salary
- Jose Ignacio Abia Buenache
- Director and Chief Executive Officer
- --
- Montse Ribas
- Chief Communications and Reputation Officer
- --
- Rahul Srinivasan
- Chief Financial Officer
- --
- Jaime Gonzalez Peralta
- Chief Digital Information Officer
- --
- Enrique de la Torre
- Chief Compliance Officer
- --
- David Ian Bell
- General Counsel, Chief Corporate Affairs and Legal Officer
- --
- Daniel Fleta Coit
- Chief Industrial Services Officer
- --
- Camille Alpi
- Chief Human Resources and Talent Officer
- --
- Dr. Jorg Schuttrumpf
- Chief Scientific Innovation Officer
- --
- Ignacio Ramal Subira
- Chief Internal Audit and Enterprise Risk Manager
- --
- Lluis Pons Gomez
- Senior Vice President, Strategy
- --
- Thomas H. Glanzmann
- Executive Chairman of the Board
- --
- Raimon Grifols Roura
- Vice Chairman of the Board
- 58.33K
- Jordi Balsells Valls
- President, Plasma Procurement
- --
- Dr. Roland Wandeler, PhD
- President, Biopharma Business Unit
- --
- Dr. Antonio Martinez Martinez
- President, Diagnostic
- --
- Víctor Grifols Deu
- Director
- 58.33K
- Tomas Daga Gelabert
- Director
- --
- Paul S. Herendeen
- Director
- 6.30K
- Albert Grifols Coma-Cros
- Director
- 100.00K
- Susana Gonzalez Rodriguez
- Independent Director
- 125.00K
- Montserrat Munoz Abellana
- Lead Independent Director
- 150.00K
- Enriqueta Felip Font
- Independent Director
- 125.00K
- Anne-Catherine Berner
- Independent Director
- 75.00K
- Pascal Ravery
- Independent Director
- 6.30K
- Inigo Sanchez-Asiain Mardones
- Independent Director
- 150.00K
- Nuria Martin Barnes
- Secretary
- --
- Laura de la Cruz Galan
- Vice Secretary
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
